
The randomised controlled trial, which has not yet begun recruiting participants, will see 568 manuscripts, submitted to one of two journals, reviewed either by scientific reviewers only (the ‘control’ group) or by scientific reviewers as well as one of 24 lay members of the public. The lay trial participants will receive training in reviewing manuscripts and will adhere to journal requirements. Reviewed articles will proceed through the journals’ editorial review processes as normal, with editors using all available reviews to aid their decisions.
The study investigators hypothesise that lay review comments will prove useful to journal editors and will have a clear impact on published manuscripts. They suggest that lay reviewers “will be more likely to comment on relevance to patients and communities, subject diversity, social context, and implementation barriers”.
——————————————————–
Summary by Hannah Mace MPharmacol, CMPP from Aspire Scientific
Categories
